Press Releases News / Events Overview Press Releases In The News IR Calendar Email Alerts Year All Years 2020 2019 Category All Releases Financial Releases NeuBase Therapeutics to Ring the NASDAQ Closing Bell Today Aug 07, 2019 8:00am EDT NeuBase Therapeutics Announces Addition of Industry Pioneer Dr. Samuel Broder and World-Renowned Geneticist Dr. George Church to Scientific Advisory Board Jul 30, 2019 8:00am EDT NeuBase Therapeutics Appoints Danith Ly, Ph.D. as Chief Scientific Officer Jul 24, 2019 8:00am EDT NeuBase Therapeutics Initiates Trading on NASDAQ Under Ticker Symbol “NBSE” Jul 15, 2019 10:20am EDT NeuBase Therapeutics Closes Merger Transaction with Ohr Pharmaceutical Jul 12, 2019 9:28am EDT NeuBase Therapeutics to Participate in Roth RNA Revolution Conference Jul 11, 2019 8:00am EDT NeuBase Therapeutics to Present at the LD Micro Conference Jun 05, 2019 9:55am EDT NeuBase Therapeutics Designates Industry Leaders to Board of Directors May 16, 2019 8:00am EDT NeuBase Therapeutics Announces Agreements for $9 Million Financing Mar 11, 2019 3:00am EDT Prev 1 2 3
NeuBase Therapeutics Announces Addition of Industry Pioneer Dr. Samuel Broder and World-Renowned Geneticist Dr. George Church to Scientific Advisory Board Jul 30, 2019 8:00am EDT
